Maria Laura Tanda - Concepedia

Author

Maria Laura Tanda

Also Known As

A. Giampietro, M L Tanda, M Tanda, M. L. Tanda, M. Tanda, M.L. Tanda, MARIA LAURA TANDA, ML Tanda, Maria L Tanda, Maria L. TANDA

229

Publications

7.3K

Citations

H-Index

Concepts

All Affiliations

University of Insubria University of Pisa Istituti di Ricovero e Cura a Carattere Scientifico Azienda Ospedaliera Universitaria Pisana Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

About

Maria Laura Tanda is an author at University of Insubria specializing in medicine, thyroid disorders, and thyroid physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	22	1.5K
2	Endocrinology	6	6	132
3	Public Health	2	2	76
4	Epidemiology	1	1	64
5	Global Health	1	1	34

Maria Laura Tanda

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy Luigi Bartalena, George J. Kahaly, L. Baldeschi, European Journal of Endocrinology Translational MedicineParathyroid HormonePharmacologyThyroid DiseaseThyroid Disorders	2021	893
Relation between Therapy for Hyperthyroidism and the Course of Graves' Ophthalmopathy Luigi Bartalena, Claudio Marcocci, Fausto Bogazzi, New England Journal of Medicine	1998	714
Prevalence and Natural History of Graves' Orbitopathy in a Large Series of Patients With Newly Diagnosed Graves' Hyperthyroidism Seen at a Single Center Maria Laura Tanda, Eliana Piantanida, Luigi Liparulo, The Journal of Clinical Endocrinology & Metabolism	2013	320
Comparison of the Effectiveness and Tolerability of Intravenous or Oral Glucocorticoids Associated with Orbital Radiotherapy in the Management of Severe Graves’ Ophthalmopathy: Results of a Prospective, Single-Blind, Randomized Study Claudio Marcocci, Luigi Bartalena, Maria Laura Tanda, The Journal of Clinical Endocrinology & Metabolism	2001	254
Lower Dose Prednisone Prevents Radioiodine-Associated Exacerbation of Initially Mild or Absent Graves’ Orbitopathy: A Retrospective Cohort Study Adriana Lai, L. Sassi, Emanuele Compri, The Journal of Clinical Endocrinology & Metabolism	2010	127
The course of Graves' ophthalmopathy is not influenced by near total thyroidectomy: a case‐control study Marcocci, Bruno‐Bossio, Luca Manetti, Clinical Endocrinology	1999	108
Characteristics of a nationwide cohort of patients presenting with isolated hypogonadotropic hypogonadism (IHH) Marco Bonomi, Valeria Vezzoli, Csilla Krausz, European Journal of Endocrinology	2017	98
Diagnosis and management of amiodarone‐induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association Luigi Bartalena, Wilmar M. Wiersinga, Maria Laura Tanda, Clinical Endocrinology	2004	88
Impact of Lithium on Efficacy of Radioactive Iodine Therapy for Graves’ Disease: A Cohort Study on Cure Rate, Time to Cure, and Frequency of Increased Serum Thyroxine After Antithyroid Drug Withdrawal Fausto Bogazzi, Clara Giovannetti, Rezene Fessehatsion, The Journal of Clinical Endocrinology & Metabolism	2009	86
Antithyroid drug treatment for Graves’ disease: baseline predictive models of relapse after treatment for a patient-tailored management E. Masiello, Giovanni Veronesi, Daniela Gallo, Journal of Endocrinological Investigation Patient-tailored ManagementMedicineThyroid DiseaseGraves ’ DiseaseAntithyroid Drug Treatment	2018	83

Page 1